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JACC Fchnl;try 1~)9~ ,,'~HS'rRA('T~,, P..tcr 22~J~, 
GUSTO-I (223i, IMPACT-I (100), PARADIGM (229) and PRIME (t?4) ..~ub- 
lishod STATIC (% STREC from enroUing fo 3 hrs ECG) and CONTINUOUS 
msthods (% STREC from flue peak fo 3 hrs ST levels; lime to STABt F 
STREC of _.50% lasbng .4 hrs; and LATE ST m-elevahon after STABLE 
ST), wore correlated va meier chn,cat endpomts (MACE = desth, CHF, re*MI), 
al~l d~afh ~lone Unrvanablo Results (% or median vnluas as yes vs no) 
V~.abte MACE p,v~lue DEATH p-yahoo 
STATIC 50% 6r % V~ It~= 0 Ott 53% V~. (~7% 00fll~ 
CONTIN ~ 50% ;'9% vs 84% 0 051 09% w 63% 0 038 
Stable ST Imm) 14F, vs t06 0 001 142 vs r13 0 ;~64 
Late ~;T .~ :=~~; *" .  - 00001 39% VS r2% 000'1 
In mulhvanablo regression, only Late ST was a s~gn~ficant predictor Com- 
pared to Static ECG a~sessment, continuous ECG m0nitonng over the course 
of MI significantly enhances 111o predict=re infom'~ahon content o! STREC for 
~,.,ca, o.t~o,,~s. 
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Diagnosis of Acute Myocardial Infarction With 
Lelt Bundle Branch Block 
IBA. Menown, J. Allen, J. AndePaon, AAJ .  Adgey. Reg~onaIMealcal 
Card~Vogy Centre, Royal V~ctona Hesp~tal, & University of Ulster, Belfast, UK 
~g"oUnd.  Detechon el i~'ulo myocardial mtarohon (AMI) w~th left bundle 
branch block (LBBBi remains a o'~agnost~c challenge Sgarbessa's recent 
ECG a~gonthm fm AMI w~th LBBB from the GUSTO-1 thai had a sensitivity 
of only 36% when validated. The maionty el leads for opbmal classification 
of Mf probably he outs~le area covered by the 6 praecordlal leads, thus body 
surface ,-napping (BSM) may be more helptul than the 124ead ECG. 
Met~mds: We evaluated the d~agnost~c patont~al of BSM using a screen- 
pnnted 64-electrode antermr harness and 16.-ele~rode postenor harness 
applied to the chest wall. We assessed 604 om'tsecutn~e patient adm~ssmns 
with chest pain (- 6 hours) duration between Aug95-Dec96 (AM1238, not AMI 
366). and 151 volunteer controls w~thout chest pa~n. LBBB was present tn 
22./604 pabents and 19/151 controls. A 124ead ECG and 80-teed BSM were 
obtained *n patronts and controls, and cardiac enzymes m patients. ORS and 
STT isemtegral (area) maps and an STSO ~sopotenhal map (potential 60 ms 
a~tcr the J point), were derrved from each BSM. 
Results: Eight of the 22 patients had AMI (max=mum CK,  2x normal). 
Only 1/8 l,alfilled ECG cnte.a for AMI with LBBB according to Sgarl~ssa's 
scortncj system. BSM analysis showed that m both controls and patients 
without AMI. Ioc~ of maxima and minima typm.ally reversed posdions when 
companng the QRS ~sointegral map with the STT isomtegral and'or STSO 
=sopotentlal maps i.e a vector shift of 180 '~ (+~15% In contrast, patients 
w;th AMI showed a vector shift outside these bruits Th~s technique correctly 
cdentdied AMI in 6/8 pabents (75% sens~hvlty) and excluded AMI =n 12/14 
pabents (86%) and 18/19 controls (95%) *e  an overatl specificity ot 91% 
Conclusion: When compared with the 12-lead ECG, analysis of vector 
patterns from BSM appears a promising method of detecting AMI ~n patients 
with chest pare and LBBB. 
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In patients (pls) presenting to the Emergency Department (ED) w~th possible 
ischemia, acute perfusion imaging with Tc-99m-sostamtbi (Tc-m=b*) can tden- 
lily high risk pts among those who initially appear by ECG and clinical cntena 
to be tow risk. Whether injection of Tc-mibl dunng symptoms ts ,;:_~,'essery for 
high sensitivity is unclear. 
Methods: We retrospectively evaluated 1669 consecutwe pts presenhng 
to the ED with possible ~schemia over a 37 month penod, all of whom were 
admitted after undergoing acute rest Tc-m~bi imaging. End-points included 
MI or revasculanzation. 
Results: The sensitivities of perlus~on imaging for predicting adverse 
cardiac outcomes when injected with and without symptoms were compared: 
With (n = 719) Wdt~out (n = 9501 P value 
MI (n = 94) 90% 93% O 50 
Flev (n = 142) 60% 72% 0.r6 
MI or Rev (n = 236) 74°0 79°0 0.37 
Conclusion: The sensitivity of perfusion imaging was nnt reduced when 
Te-mibi was injected in symptom-tree patients. 
1083-1321 Acute Myoca~llal Infarction With Isolated 
ST-Segment Elevation in Posterior Chemt Leads: 
VT~ 
S Matelzky, D Frelmark, B Rabmowtlz. S Rath 0 Aqfan¢~t, E Kaphflsky, 
kl HOd H(~gn !nstlrlJte, Sne~J~// Mc~,(~tc~l Cen~r at~ Tc, I.Avrv Unw~m~. Israel 
The etectrOcardiOgraph¢ diagno~is o! poster, or acute myocardial mfacl~On 
(AMI) *S based on indirect "mirr~ ,mage" char~ges tn the preCort~at 
These change~ ate neither Sensltwe nor Speoh¢ and do no! consist of ehg~e 
cntena for thrombelysis. We describe tt'0e charactenstlcs Of 24 pts w~th AMI 
and ,solafed ST ? *n the postenof chest leads V~-~ on admisslof't ECG 
On disCharge ECG: Pathologic O-waves appeared tn V? ~ tn 19 pt~ ('Z9%) 
and R ~ =n V,-~ =n 18 pts (75%). 
2DE; Aklnegis or hy~k l~ lS  was demonstrated in the poSten0r Seg- 
ments *n 96% and In the *nf¢flor or lateral ~ 'nents  *n 43% of the pts. Mlfral 
regurg~tat~ was found in 70'~.. and was modarate.~were in22% ot the pts. 
Coronary angmgraphy: 12 pts were cafl'~efenzed The Outpnt lesion was 
~n the m~d-C~ ,n 10 pts (83%) and ,n the proximal marginal ,n 2 pts (17%) 
Clinical outcome: The mean peak CK was 698 ¢ 3,?B i u./mt The foitowmg 
advee~e events were holed: sinus bfadycardia or CAVB m 5 (21%); PAF =n 
3 (12 5%): NSVT in 3 (12.5%); post MI angma *n 7 (29%) and CHF m 2 pts 
(8%) One pt died of free wall rupture m the postenor wall (PM). 
Conclusions: t l  In pts with tschem~c chest pain but wlthout ST ~ ,n e~ther 
of the 12 leads oi the classic ECG, ST ~ =n V~_~ might be the only evtclence 
of true posl MI ~n the hyperacute stage. 2) tn all these pts the Cx was the 
mfarot-related artery 
{ 1083-133 ] l~'oponin I ~ s  in Unstable Anglna/Non-O 
Wave Myoc~la l  InMmt ion  Patlente 
With T i rof lban,  a G lycoprote in  I IM l la  An lz~on la t  
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Background- Elevahon el Troponin t in patients wrlh unstable angmaJnon-Q 
wave myocardial mfarst~on rs as~ated  wdh ~mpalred short and long term 
prognoses. In thzs study, we evaluated if t]rehban could modify the blood level 
of the marker 
Metho~ Senal Tmponin I levels were measured over the initial 24 hours 
after enrollment *n the PRISM-PLUS tnal, which compared the effects el hop- 
ann vs. hepann plus tzrofiban in ~s with documented unstable angm~non-O 
wave MI. 
Results: There was no s~gniticant difference tn the baseline Trop~nin t 
levels between the hepann (52 pts) and the combinahon therapy (53 pts) 
groups: 31 = 67vs.  16 ~: 30 ng/mL (mean ¢ SD),p =015 The peak 
Troponm I level was s~gn~ficantly h~gher Jn the hepann group (15.5 t 29.1 
nojmL) compared wdh the combination group (5.2 ~- 8.3 ng/mL), p = 0.017. 
The mean Trepomn I levels over imtlal 24 hOur penod were 85 ¢ 14.8 vs 
3 2 : 5.0 .g/mL (p = 0 016), respectively 
Conclusion: In th~s patient poputabon treatment with hrefiben prevents 
the increase of Tropomn I levels indicative el myO(~rdtal injury and poor 
prognosrs This result ~s consistent with the climcal OUtcome of the study which 
showed that combmabon therapy resulted =n a reduction m the incidence oi 
adverse cardiac events. 
t 1 083-134 t Even Low Pos i t ive  Troponln T Vslues Ident i fy  
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Background: Although Troponm T (TnT) ~s a useful altematwo to CKMB m 
the eady diagnos~s of coronary syndromes, ~ts independent pro<jnoshc value 
remains uncertain. 
Methods: We mca:ured both serum markers at 0, 4, 8 and 16 hours m 
a broad populabon with suspected ischemia, including hospitalized pal,ents 
and those admitted to a shod stay chest pain unit. Treating physioans were 
blinded to TnT values. Patients were followed for m-hospital events and 
interviewed 6.3 ± 0.9 months following discharge to determine the inodence 
of late complications Adverse events included infarction. CHF. recurrent 
ischemia, stroke, need for catheterization and intervention, coronary surgery 
and/or death. 
Results: Of 707 patients. 51 were excluded for creattnme ,2 mg~dl. 
In-hospital adverse events occurred in stmi)ar proportions in CKMB and TnT 
positive patients, but v, qth 59.3% of events in patients wcth negative serum 
markers. Follow-up was obtained in 582 (89%). Late adverse eve=,ts occurred 
in 28.9% an average of 3.3 ± 2.5 months following d~scharge w~n sinking 
differer~:,es between subgroups: 
